Rheumatoid Arthritis (RA)

RA is a chronic autoimmune disorder where the body’s own immune system causes damages to the native organs.

Although the most prominent symptoms for RA are associated with the joints, there are also other organs such as the heart and skin that may be infected. The treatment for RA usually involves systemic anti-inflammatories, which is associated with complications. Often, the patients will still present with severe joint pain flares, which are often treated with local injection of steroids and anesthetics.

Most common injection used is steroids which although may relieve the pain but are also associated with further joint damage. Neutrophil nanosponge has demonstrated an ability to neutralize the proinflammatory cytokines in the synovial fluids of RA patients and may present a potential joint sparing treatment for RA patients with severe joint presentation.